Development of all-in-one CRISPR/Cas9 and CRISPRi AAV constructs to treat autosomal dominant retinitis pigmentosa
<p>Dominant mutations in RHO (rhodopsin) are the most common cause of autosomal dominant retinitis pigmentosa (RHO-adRP). RHO-adRP causes progressive loss of rod cells, followed by cone cells, leading to blindness. This disease is a candidate for CRISPR gene editing, as reduction of mutant rho...
Príomhchruthaitheoir: | Peddle, CF |
---|---|
Rannpháirtithe: | MacLaren, RE |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
2021
|
Ábhair: |
Míreanna comhchosúla
Míreanna comhchosúla
-
Rhodopsin mutations are scarcely implicated in autosomal recessive retinitis pigmentosa: A preliminary study of Egyptian retinitis pigmentosa patients
de réir: Reem Mebed, et al.
Foilsithe / Cruthaithe: (2015-10-01) -
AAV-CRISPR/Cas9 Gene Editing Preserves Long-Term Vision in the P23H Rat Model of Autosomal Dominant Retinitis Pigmentosa
de réir: Saba Shahin, et al.
Foilsithe / Cruthaithe: (2022-04-01) -
Herencia de la retinosis pigmentaria en la provincia Camagüey Inheritance of retinitis pigmentosa in the province of Camagüey
de réir: Elisa Dyce Gordon, et al.
Foilsithe / Cruthaithe: (1999-06-01) -
Whole exome sequencing reveals novel EYS mutations in Chinese patients with autosomal recessive retinitis pigmentosa
de réir: Xiaoqiang Xiao, et al.
Foilsithe / Cruthaithe: (2019-01-01) -
Genetic dissection of non-syndromic retinitis pigmentosa
de réir: Aarti Bhardwaj, et al.
Foilsithe / Cruthaithe: (2022-01-01)